Active substanceDiclofenacDiclofenac
Similar drugsTo uncover
  • Argett Duo
    capsules inwards 
  • Argett Rapid
    capsules
  • Voltaren®
    patch externally 
  • Voltaren®
    patch externally 
  • Voltaren®
    spray externally 
  • Voltaren®
    suppositories rect. 
    Novartis Pharma AG     Switzerland
  • Voltaren®
    pills inwards 
  • Voltaren®
    pills inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren®
    solution w / m 
    Novartis Pharma AG     Switzerland
  • Voltaren®-Flotac®
    capsules inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren® Acti
    pills inwards 
  • Voltaren® Ophta
    drops d / eye 
  • Voltaren Rapid
    powder inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren Rapid
    pills inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren® Emulgel®
    gel externally 
  • Voltaren® Emulgel®
    gel externally 
  • Diclac®
    pills inwards 
    Sandoz d.     Slovenia
  • Diclac®
    suppositories rect. 
    Sandoz d.     Slovenia
  • Diclac®
    solution w / m 
    Sandoz d.     Slovenia
  • Diclac®
    gel externally 
    Sandoz d.     Slovenia
  • Diclac® Lipogel
    gel externally 
    Sandoz d.     Slovenia
  • Diklo-F
    drops d / eye 
  • Diklovit®
    gel externally 
  • Diklovit®
    suppositories rect. 
  • Diklogen®
    pills inwards 
  • Diklogen®
    gel externally 
  • Diklogen®
    pills inwards 
  • Diklogen®
    solution w / m 
  • Diklogen®
    gel externally 
  • Diclonat® P
    solution w / m 
  • Dicloran®
    gel externally 
  • Diclofenac
    suppositories rect. 
    FARMENT FIRM, LLC     Russia
  • Diclofenac
    solution w / m 
    GROTEKS, LLC     Russia
  • Diclofenac
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    pills inwards 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    ointment externally 
  • Diclofenac
    suppositories rect. 
  • Diclofenac
    gel externally 
  • ATOLL, LLC     Russia
  • Diclofenac
    solution w / m 
    ATOLL, LLC     Russia
  • Diclofenac
    solution w / m 
    ELLARA, LTD.     Russia
  • Diclofenac
    solution w / m 
    ALVILS, LTD.     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
  • Diclofenac
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    ointment externally 
    ATOLL, LLC     Russia
  • Diclofenac
    solution w / m 
    DALHIMFARM, OJSC     Russia
  • Diclofenac
    ointment
    GREEN DUBRAVA, CJSC     Russia
  • Diclofenac
    suppositories
    ALTAYVITAMINS, CJSC     Russia
  • Diclofenac
    pills inwards 
  • Diclofenac
    solution w / m 
  • Diclofenac
    suppositories rect. 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
  • Diclofenac
    pills inwards 
  • Diclofenac
    solution w / m 
  • Diclofenac
    suppositories rect. 
  • Diclofenac
    gel externally 
    ELFA NPC, CJSC     Russia
  • Diclofenac
    suppositories rect. 
    DALHIMFARM, OJSC     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    ointment externally 
  • Diclofenac
    pills inwards 
    ZIO-HEALTH, JSC     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    solution w / m 
    Hanmi Farm. Co., Ltd     The Republic of Korea
  • Diclofenac
    pills inwards 
  • Diclofenac
    pills inwards 
  • Diclofenac
    drops d / eye 
  • Diclofenac
    solution w / m 
  • Diclofenac
    pills inwards 
  • Diclofenac
    pills inwards 
  • Diclofenac
    solution
  • Diclofenac
    suppositories rect. 
    Magister KiK     Romania
  • Diclofenac
    gel externally 
    Hemofarm AD     Serbia
  • Diclofenac
    solution w / m 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    ointment externally 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    pills inwards 
    Natur Product Europe BV     Netherlands
  • Diclofenac
    suppositories rect. 
    FARMAPRIM, LLC     The Republic of Moldova
  • Diclofenac
    solutionpills inwards w / m 
  • Diclofenac
    pills inwards 
    OZONE, LLC     Russia
  • Diclofenac
    drops d / eye 
  • Diclofenac
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    gel externally 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
    ATOLL, LLC     Russia
  • Diclofenac
    gel externally 
  • Diclofenac Wellpharm
    solution w / m 
    VELFARM, LLC     Republic of San Marino
  • Diclofenac Grindeks
    ointment externally 
    GRINDEX, JSC     Latvia
  • Diclofenac retard
    pills inwards 
    OZONE, LLC     Russia
  • Diclofenac retard-Akrihin
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Diclofenac Sandoz®
    pills inwards 
    Sandoz d.     Slovenia
  • Diclofenac Sandoz®
    pills inwards 
    Sandoz d.     Slovenia
  • Diclofenac Stade®
    pills inwards 
  • Diclofenac Stade®
    pills inwards 
  • Elf Diclofenac
    solution w / m 
  • Diclofenac-Akos
    solution w / m 
    SYNTHESIS, OJSC     Russia
  • Diclofenac-Akos
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Diclofenac-Acrychin®
    gel externally 
    AKRIKHIN HFK, JSC     Russia
  • AKRIKHIN HFK, JSC     Russia
  • Diclofenac-Acrychin
    gel externally 
    AKRIKHIN HFK, JSC     Russia
  • Diclofenac-Altpharm
    suppositories rect. 
    ALTFARM, LLC     Russia
  • Diclofenac-MFF
    suppositories rect. 
  • Diclofenac-MFF
    ointment externally 
  • Diclofenac-ratopharm
    suppositories rect. 
    ratiofarm GmbH     Germany
  • Diclofenac-SOLOfarm
    drops d / eye 
    GROTEKS, LLC     Russia
  • Diclofenac-Teva
    gel externally 
  • Diclofenac-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Diclofenac-FPO
    pills inwards 
  • Diclofenac-Eskom
    solution w / m 
    ESKOM NPK, OAO     Russia
  • Diclofenaclong®
    drops d / eye 
    FIRN M, ZAO     Russia
  • Diclofenacol
    cream externally 
    Hiperion S.A.     Romania
  • Dorosan
    aerosol externally 
    Rottafarm SpA     Italy
  • Naklofen
    solution w / m 
  • Naklofen
    pills inwards 
  • Naklofen
    suppositories rect. 
  • Naklofen
    gel externally 
  • Naklofen Duo
    capsules inwards 
  • Naklofen Protect
    capsules inwards 
    KRKA-RUS, LLC     Russia
  • Naklofen SR
    pills inwards 
  • Orthophene
    gel externally 
    VERTEKS, AO     Russia
  • Orthophene
    solution w / m 
  • Orthophene
    pills inwards 
  • Orthophene
    ointment externally 
    VERTEKS, AO     Russia
  • Orthofer®
    ointment externally 
    BRYNTSALOV-A, CJSC     Russia
  • Orthofer®
    pills inwards 
    BRYNTSALOV-A, CJSC     Russia
  • Orthofer®
    solution w / m 
    BRYNTSALOV-A, CJSC     Russia
  • Penseid
    solution externally 
    NovaMedika, OOO     Russia
  • Rapten Duo
    pills inwards 
    Hemofarm AD     Serbia
  • Rapent Rapid
    pills inwards 
    Hemofarm AD     Serbia
  • Rapent Rapid
    pills inwards 
    Hemofarm AD     Serbia
  • Tabuk-Di
    pills inwards 
  • The Flector
    patch through. 
  • Dosage form: & nbsp
    Suppositories rectal.

    Composition:
    1 suppository contains
    active substance:
    Diclofenac sodium - 100 mg
    Excipients:
    cetyl alcohol 20 mg, semi synthetic glycerides (Suppocire) - a sufficient amount to obtain a suppository with a mass of 2000 mg.
    Description:White or white with a yellowish tinge of the suppository cylindroconical shape. On the cut, an air rod or a funnel-shaped depression is allowed.
    Pharmacotherapeutic group:Non-steroidal anti-inflammatory drug (NSAID).
    ATX: & nbsp

    S.01.B.C.03   Diclofenac

    M.01.A.B.05   Diclofenac

    Pharmacodynamics:Non-steroidal anti-inflammatory drug, a derivative of phenylacetic acid. Has anti-inflammatory, analgesic and antipyretic effect. By indiscriminately inhibiting cyclooxygenase 1 and 2 (COX1 and COX2), it disrupts the metabolism of arachidonic acid, reduces the amount of prostaglandins in the inflammatory focus.The most effective for inflammatory pain. In rheumatic diseases, the anti-inflammatory and analgesic effect of diclofenac significantly reduces the severity of pain, morning stiffness, swelling of the joints, which improves the functional state of the joint. With injuries, in the postoperative period diclofenac reduces pain and inflammatory swelling. Like all NSAIDs, the drug has antiaggregant activity.
    Pharmacokinetics:
    With rectal administration. TCmax is 0.5 - 2 hours, the maximum concentration is on average; about 1.5 mg / ml. The concentration in the plasma is linear depending on the amount of the administered dose. Changes in the pharmacokinetics of diclofenac against a background of repeated administration are not noted, the drug does not cumulate while observing the recommended interval between meals.

    The association with plasma proteins is more than 99% (most of it is associated with albumins). Penetrates into the synovial fluid. The maximum concentration in the synovial fluid is observed 2-4 hours later than in the plasma. The half-life of the synovial fluid is 3-6 hours (the concentration of the active substance in the synovial fluid 4-6 hours after the administration of the drug is higher than in the plasma, and remains higher for another 12 hours).The relationship between the concentration of the drug in the synovial fluid and the clinical efficacy of the drug has not been elucidated. Metabolism: 50% of the active substance is metabolized during the "first pass" through the liver. Metabolism occurs as a result of repeated or odifikatnogo gidroksylirovaniya and conjugation with glucuronic acid. The enzyme system P450 CYP2C9 takes part in the metabolism of the drug. The pharmacological activity of metabolites is lower than that of diclofenac. The system clearance is about 350 ml / min, the volume of distribution is about 550 ml / kg.

    The half-life from the plasma averages about 2.5 hours. 65% of the administered dose is excreted as metabolites by the kidneys; less than 1% is unchanged, the rest of the dose is excreted as metabolites with bile.

    In patients with severe renal insufficiency (creatinine clearance less than 10 ml / min), the excretion of metabolites with bile is increased, while the increase in their concentration in the blood is not observed. In patients with chronic hepatitis or compensated cirrhosis, the pharmacokinetic parameters of diclofenac do not change.

    Diclofenac penetrates into breast milk.
    Indications:
    Symptomatic treatment of diseases of the musculoskeletal system (rheumatoid arthritis, psoriatic, ankylosing spondylitis, gouty arthritis, rheumatic soft tissue damage, osteoarthrosis of peripheral joints and spine, including radicular: syndrome, tendovaginitis, bursitis). The drug removes or reduces pain and inflammation during the treatment period, without affecting the progression of the disease.

    Pain syndrome of mild or moderate severity: neuralgia, myalgia, lumboschialgia, posttraumatic pain syndrome, accompanied by inflammation, postoperative pain, headache, migraine, algodismenorea, adnexitis, proctitis, toothache.

    In the complex therapy of infectious and inflammatory diseases of the ear, throat, nose with severe pain syndrome (pharyngitis, tonsillitis, otitis).
    Contraindications:
    - Period after aortocoronary bypass surgery;

    - III trimester of pregnancy, the period of breastfeeding;

    - Uncompensated heart failure;

    - Hypersensitivity to the active substance or ancillary components;

    - Anamnestic data on an attack of bronchial obstruction, rhinitis, hives after taking acetylsalicylic acid or other NSAIDs (complete or incomplete acetylsalicylic acid intolerance syndrome - rhinosinusitis, urticaria, polyps of the nasal mucosa, asthma bronchial);

    -Erosively-ulcerative changes in the gastric mucosa or duodenum, active gastrointestinal bleeding;

    - Inflammatory bowel disease (ulcerative colitis, Crohn's disease);

    -Cerebrovascular bleeding or other bleeding and hemostasis disorders;

    -Different hepatic impairment or active liver disease;

    -Different renal failure (creatinine clearance less than 30 ml / min), progressive kidney disease, incl. confirmed hyperkalemia.

    -Children's age (up to 18 years).

    -Rectal bleeding, hemorrhoids, trauma or inflammation of the rectum.
    Pregnancy and lactation:

    Dosing and Administration:
    Rectally. Adults before using the suppository are recommended to relieve the intestines.

    Usually, one suppository is used in the evening as a single daily dose.

    The maximum daily dose, considering the possibility of using other dosage forms-150 mg.

    It is advisable to share with oral forms of diclofenac as the last dose of daily treatment instead of oral administration. For example, if the daily dose is 150 mg, one tablet of 50 mg is administered orally throughout the day and one suppository rectally in the evening (overnight).

    At a migraine attack - one suppository of 100 mg at the first signs of an attack.

    The duration of use of the drug is not more than 7 days.
    Side effects:

    Often - 1-10%; sometimes 0.1-1%; rarely - 0,01-0,1%; very rarely - less than 0.001%), including individual cases.

    From the digestive system: often - epigastric pain, nausea, vomiting, diarrhea, dyspepsia, flatulence, anorexia, increased activity of aminotransferases; rarely - gastritis, proctitis, bleeding from the digestive tract (vomiting with blood, melena, diarrhea with a trace of blood), gastrointestinal ulcers (with or without bleeding or perforation), hepatitis, jaundice, impaired liver function; very rarely - stomatitis, glossitis, damage to the esophagus, diaphragm-like intestinal strictures (nonspecific hemorrhagic colitis,exacerbation of ulcerative colitis or Crohn's disease), constipation, pancreatitis, fulminant hepatitis, exacerbation of hemorrhoids (for rectal suppositories).

    From the nervous system: often - headache, dizziness; rarely - drowsiness; very rarely - a violation of sensitivity, incl. paresthesia, memory disorders, tremors, convulsions, anxiety, cerebrovascular disorders, aseptic meningitis, disorientation, depression, insomnia, nightmares, irritability, mental disorders.

    From the sense organs: often - vertigo; very rarely - visual impairment (blurred vision, diplopia), hearing impairment, tinnitus, a violation of taste sensations.

    From the urinary system: very rarely - acute renal failure, hematuria, proteinuria, interstitial nephritis, nephrotic syndrome, papillary necrosis.

    From the hematopoiesis: very rarely - thrombocytopenia, leukopenia, hemolytic and aplastic anemia, agranulocytosis.

    Allergic reactions: anaphylactic / anaphylactoid reactions, including a marked decrease in blood pressure and shock; very rarely - angioedema (including face).

    From the cardiovascular system: very rarely - palpitations, chest pain, increased blood pressure, vasculitis, heart failure, myocardial infarction.

    From the respiratory system: rarely - bronchial asthma (including dyspnea); very rarely - pneumonitis.

    From the skin: often - skin rash; rarely - hives; very rarely - bullous eruptions, eczema, incl. multiform and Stevens-Johnson syndrome, Lyell's syndrome, exfoliative dermatitis, itching, hair loss, photosensitivity, purpura, incl. allergic.

    Local reactions with rectal administration: irritation of the mucous membrane of the rectum, mucous discharge with an admixture of blood, pain during defecation, rectal bleeding.

    Overdose:
    Symptoms: vomiting, dizziness, headache, dyspnea, confusion, in children - myoclonic cramps, nausea, vomiting, abdominal pain, bleeding, impaired liver and kidney function. Treatment: symptomatic therapy, forced diuresis. Hemodialysis is ineffective.

    In case of overdose, it is necessary to consult a doctor immediately.
    Interaction:
    Increases the concentration in the plasma digoxin, methotrexate, lithium and cyclosporine.

    Reduces the effect of diuretics, against the background of potassium-sparing diuretics increases the risk of hyperkalemia; against the background of anticoagulants, thrombolytic agents (alteplase, streptokinase, urokinase) - the risk of bleeding (more often from the gastrointestinal tract). . Reduces the effects of hypotensive and hypnotics. Increases the likelihood of side effects of other non-steroidal anti-inflammatory drugs and glucocorticosteroid agents (bleeding in the gastrointestinal tract), toxicity. methotrexate and nephrotoxicity of cyclosporine. Acetylsalicylic acid reduces the concentration of diclofenac in the blood. Simultaneous use with paracetamol increases the risk of developing nephrotoxic effects of diclofenac. Reduces the effect of hypoglycemic agents.

    Cefamandol, cefoperazone, cefotetan, valproic acid and plikamycin increase the incidence of hypoprothrombinemia.

    Cyclosporine and gold preparations increase the effect of diclofenac on the synthesis of prostaglandins in the kidneys, which increases nephrotoxicity.Simultaneous administration with ethanol, colchicine, corticotropin and preparations of St. John's wort increases the risk of bleeding in the gastrointestinal tract.

    Diclofenac enhances the effect of drugs that cause photosensitivity.

    Drugs that block tubular secretion, increase the concentration in the plasma of diclofenac, thereby increasing its toxicity. Antibacterial drugs from the quinolone group - the risk of seizures.

    Selective serotonin reuptake inhibitors increase the risk of bleeding from the digestive tract.

    Effect on the results of laboratory tests: diclofenac can influence serum transaminase levels (if this effect is long-lasting or if complications occur, treatment should be discontinued), and may cause an increase in potassium concentrations.
    Special instructions:
    To reduce the risk of developing adverse events on the part of the gastrointestinal tract, a minimum effective dose should be used with the minimum possible short course.

    With prolonged treatment, it is necessary to monitor the functions of the liver and kidneys.

    Caution is necessary in surgical interventions, since there is a high risk of bleeding: diclofenac inhibits platelet aggregation.

    In cases of renal and hepatic insufficiency, only small doses should be used, since the level of excretion of the drug is lower.

    When using the drug, the risk of toxic gastrointestinal reactions increases.

    In patients with hypersensitivity to acetylsalicylic acid diclofenac can lead to bouts of bronchial asthma. Care must be taken when combined with ACE inhibitors, beta-blockers; digoxin; when treating nephrotoxic drugs, zidovudine.

    When using the drug, it is necessary to refrain from activities requiring increased attention and rapid mental and motor reactions, since the drug can affect the central nervous system.

    Patients taking the drug should refrain from drinking alcohol.
    Form release / dosage:
    Suppositories rectal by 100 mg.
    Packaging:
    6 suppositories in a PVC / PE film blister.

    1 blister together with instructions for use in a cardboard pack.
    Storage conditions:In a dry, dark place at a temperature of 15 to 25 ° C. Keep out of the reach of children!
    Shelf life:
    3 years.

    Do not use after the expiry date printed on the package!
    Terms of leave from pharmacies:On prescription
    Registration number:П N014866 / 01
    Date of registration:11.09.2008
    The owner of the registration certificate:FARMAPRIM, LLC FARMAPRIM, LLC The Republic of Moldova
    Manufacturer: & nbsp
    FARMAPRIM, LLC The Republic of Moldova
    Information update date: & nbsp27.02.2016
    Illustrated instructions
      Instructions
      Up